Amgen prevails against Sanofi and Regeneron

26-02-2019

Amgen prevails against Sanofi and Regeneron

clu / iStockphoto.com

A jury has upheld two of Amgen’s patents for its cholesterol drug Repatha (evolocumab), rejecting a challenge brought by two competitors.


Sanofi, Regeneron, Amgen, cholesterol drug, patent infringement, Repatha, US District Court for the District of Delaware

LSIPR